| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 08/09/2012 | US20120202854 4-substituted phenoxyphenylacetic acid derivatives |
| 08/09/2012 | US20120202781 Indane derivatives |
| 08/09/2012 | US20120202756 Use of prodrugs to avoid gi mediated adverse events |
| 08/09/2012 | US20120199385 Phenylnaphthylimidazole compound and usage of the same |
| 08/08/2012 | EP2483246A1 Process for preparing biphenyl imidazole compounds |
| 08/08/2012 | EP1169038B1 Cyclic protein tyrosine kinase inhibitors |
| 08/08/2012 | CN102627609A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors |
| 08/08/2012 | CN102627600A Multivalent nicotine compound, and preparation method and application of multivalent nicotine compound |
| 08/08/2012 | CN101679294B Non-nucleoside reverse transcriptase inhibitors |
| 08/08/2012 | CN101243053B N-acylic aminoacid derivatives, method for the production thereof, pharmacological composition and the use in the form of anti-allergic, anti-inflammatory and hypolipidemic agents |
| 08/08/2012 | CN101022728B Imidazole compounds |
| 08/07/2012 | US8236844 Histidine derivatives |
| 08/07/2012 | US8236843 Anti inflammatory compounds |
| 08/07/2012 | US8236842 Salt and process for producing acid generator |
| 08/07/2012 | US8236798 Carboxamide compounds and their use as calpain inhibitors |
| 08/07/2012 | US8236279 Bisaminoethanethiol-targeting ligand conjugates and compositions |
| 08/02/2012 | WO2012102137A1 Charge control agent and toner using same |
| 08/02/2012 | WO2012101236A1 A photoluminescent molecular complex and method for determining of the concentration of said molecular complex |
| 08/02/2012 | WO2012063085A3 Drug derivatives |
| 08/02/2012 | US20120197005 Containerless synthesis of amorphous and nanophase organic materials |
| 08/02/2012 | US20120196908 Benzyl aralkyl ether compounds, method for preparing same, intermediate compounds, use of said compounds, method for treatment and/or prevention, pharmaceutical composition and medicament containing same |
| 08/02/2012 | US20120196905 Synthetic compounds and methods to decrease nicotine self-administration |
| 08/02/2012 | US20120196884 Urea substituted sulphonamide derivatives |
| 08/02/2012 | US20120196874 Stilbene analogs and methods of treating cancer |
| 08/02/2012 | US20120196864 Prophylactic or therapeutic agent for cancer |
| 08/02/2012 | US20120196838 Compounds for inflammation and immune-related uses |
| 08/02/2012 | US20120196819 Animal treatments |
| 08/01/2012 | EP2482072A1 A photoluminescent probe |
| 08/01/2012 | EP1425000B1 Use of polysubstituted indan-1-ol systems for producing drugs used in the prophylaxis or treatment of obesity |
| 08/01/2012 | CN102625800A Benzyl aralkyl ether compounds, method for preparing same, intermediate compounds, use of said compounds, method for treatment and/or prevention, pharmaceutical composition and medicament containing same |
| 08/01/2012 | CN102619138A Preparation method of dialkylamide imidazoline quaternary ammonium salt emulsion type paper softener |
| 08/01/2012 | CN102617476A Method for synthesizing allantoin |
| 08/01/2012 | CN102617373A Amino acid modified triphenylamine organic hole transport material for all solid-state quantum dot-sensitized solar cell |
| 08/01/2012 | CN102276533B New ozagrel sodium compound and medicinal composition thereof |
| 08/01/2012 | CN101921233B Tree imidazoline quaternary ammonium salt corrosion inhibitor and preparation method thereof |
| 07/31/2012 | US8232392 Process for preparing temozolomide |
| 07/31/2012 | US8232308 Methods for treating a disease in which Rho kinase is involved |
| 07/31/2012 | US8232306 Methods for detecting sulfhydryl-containing compounds in a biological test sample |
| 07/31/2012 | CA2449999C Compounds and methods for the treatment or prevention of flavivirus infections |
| 07/26/2012 | US20120190718 Diarylthiohydantoin compounds |
| 07/25/2012 | CN102604156A 碱产生剂 Base generator |
| 07/25/2012 | CN102603647A 18/19F-ester nitroimidazole compound, preparation method thereof and application as hypoxic tissue developing agent |
| 07/25/2012 | CN102603646A Synthesis method of 4-[4-(methylsulfonyl)phenyl]-5-phenyl-2-(trifluoromethyl)-1H-imidazole |
| 07/25/2012 | CN102603645A Method for synthetizing fenflumizole |
| 07/25/2012 | CN102603644A Production method of alkylimidazole ionic liquid |
| 07/25/2012 | CN102603643A Reformation of ionic liquids |
| 07/25/2012 | CN102603642A Nickel-containing sandwich polyoxometallate anti-cancer drug and synthesis method thereof |
| 07/25/2012 | CN102603641A N-imidazolyl acetate derivative, and preparation method and application thereof |
| 07/25/2012 | CN102603640A Synthesis method of hydroxyl(amino) ethyl alkyl imidazoline surfactant |
| 07/25/2012 | CN102603619A Compound with anticancer activity and preparation method thereof |
| 07/25/2012 | CN102002000B Method for producing 5,5-dimethyl hydantoin |
| 07/25/2012 | CN101928248B Method for preparing 2-phenylimidazole compounds |
| 07/25/2012 | CN101851208B Multifunctional ion liquid preparation device |
| 07/25/2012 | CN101586186B Method for leaching chalcopyrite and corresponding leaching agent |
| 07/25/2012 | CN101405240B Reagent for organic synthesis and method of organic synthesis reaction with the reagent |
| 07/25/2012 | CN101271089B Method for identifying allantoin in Cistanche plant variety |
| 07/24/2012 | US8227610 Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques |
| 07/24/2012 | US8227499 Substituted-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors |
| 07/24/2012 | US8227498 imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents; sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents; drug abuse/withdrawl; 2-cyano(4-ethylphenyl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)guanidine |
| 07/24/2012 | US8227497 Dual-acting antihypertensive agents |
| 07/24/2012 | CA2690226C Novel malonic acid sulfonamide derivative and pharmaceutical use thereof |
| 07/19/2012 | US20120184580 Substituted di-arylhydantoin and di-arylthiohydantoin compounds and methods of use thereof |
| 07/19/2012 | US20120184518 Methods of treating or preventing an inflammatory disease or condition using glutaminyl cyclase inhibitors |
| 07/19/2012 | US20120183531 Methods for Inhibiting Yellow Color Formation in a Composition |
| 07/19/2012 | US20120183494 Novel n-halamine acrylamide monomers and copolymers thereof for biocidal coatings |
| 07/18/2012 | EP2476756A1 Amine-containing lipids and uses thereof |
| 07/18/2012 | EP2475647A1 Androgen receptor antagonists and uses thereof |
| 07/18/2012 | CN1675230B Phosphonium and imidazolium salts and methods of their preparation |
| 07/18/2012 | CN1639130B Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 07/18/2012 | CN102596915A Method for the synthesis of 2-thiohistidine and the like |
| 07/18/2012 | CN102596914A Metal polydentate ligand complex |
| 07/18/2012 | CN102596898A Tetracycline compounds |
| 07/18/2012 | CN102596321A Alkynyl derivatives useful as dpp-1 inhibitors |
| 07/18/2012 | CN102584878A Ionic liquid containing divalent boron cluster negative ion and preparation method thereof |
| 07/18/2012 | CN102584813A Compouds and uses thereof in modulating amyloid beta |
| 07/18/2012 | CN102584712A Diarylhydantoin compounds |
| 07/18/2012 | CN102584711A 3-benzyloxy-hydantoin with antineoplastic activity |
| 07/18/2012 | CN102584710A Chloric perfluorocyclopropane carboxylic ester type compound as well as preparation and application thereof |
| 07/18/2012 | CN102584709A Improved process for preparing aryl imidazole aldehyde serving as eprosartan intermediate |
| 07/18/2012 | CN102584708A Heteropoly-based ionic liquid electrolyte and preparation method thereof |
| 07/18/2012 | CN102050789B Method for extracting and purifying allantoin from purple yam |
| 07/18/2012 | CN101084196B Process for producing n-halogenated organic compounds |
| 07/17/2012 | CA2469187C Cis-2,4,5-triphenyl-imidazolines and their use in the treatment of tumors |
| 07/12/2012 | WO2012093688A1 Imidazole compound production method, imidazole compound, imidazole-based compound, organic metal complex, material for organic electroluminescent element, organic electroluminescent element, display device, and lighting device |
| 07/12/2012 | US20120178769 Novel compounds for inhibiting eef-2 kinase activity |
| 07/12/2012 | US20120178666 Prodrugs of guanfacine |
| 07/11/2012 | EP2474534A1 3-Aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity |
| 07/11/2012 | EP2474527A1 Ionic liquid containing allylsulfonate anion |
| 07/11/2012 | EP2190823B1 Halosubstituted aryloxyalkylimidazolines for use as pesticides |
| 07/11/2012 | EP1471056B1 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 07/11/2012 | CN102574811A Diamine compound, polyamic acid, polyimide, and liquid crystal aligning agent |
| 07/11/2012 | CN102574785A Tetra-substituted heteroaryl compounds and their use as MDM2 and/or MDM4 modulators |
| 07/11/2012 | CN102574778A Novel biphenyl and phenyl-pyridine amides |
| 07/11/2012 | CN102558064A Antihypertensive compound, and its preparation method, application and pharmaceutically acceptable salts and solvates |
| 07/11/2012 | CN102558063A Preparing method of 1, 3-four carboxylic acid ester ionic liquid |
| 07/11/2012 | CN102558062A Method for synthesizing imidazole-amino acid derivative and related compound |
| 07/11/2012 | CN102558061A Synthetic method of ozagrel |
| 07/11/2012 | CN102558060A Process for preparing imidazolidine |
| 07/11/2012 | CN102557987A Method for preparing sartan antihypertensive drug side-chain |
| 07/11/2012 | CN102557982A Certain chemical entities, compositions, and methods |